Combination Therapy for MPN Patients

Published on

Topics include: Treatments

Dr. Ruben Mesa, deputy director at Mayo Clinic Cancer Center, provides an update on where we stand with single agents and combination therapy to treat MPNs. Dr. Mesa details current and developing therapies and what they might mean for some MPN patients. Dr. Mesa discusses the broad spectrum of ongoing clinical trials for MPNs and is hopeful that research he and his colleagues are leading will help to yield more effective treatments that extend survival. 

View more programs featuring

Produced in association with

Related Programs

Understanding Disease Burden Among MPNs

Is it possible to pinpoint the source of symptoms in MPNs? Not always, according to Drs. Ruben Mesa and Jorge Cortes. Both experts focus on understanding disease burden among MPNs.


Defining the MPN Blast Phase

Mayo Clinic expert, Dr. Ruben Mesa, defines the “MPN blast phase,” what’s normal and why these cells are closely monitored.


Why Do MPNs Progress?

Dr. Ruben Mesa of Mayo Clinic fills us in on what he and his colleagues are learning about why myeloproliferative neoplasms progress and whether we might be able to measure these group of diseases soon.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on March 19, 2014